Lifecare ASA will hold a General Meeting on 24 April 2025, at 16:30 (CEST).
The meeting will be conducted as a combined physical and digital meeting.
Shareholders who wish to participate and vote at the General Meeting must be
registered with a userprofile in the meeting portal Orgbrain
(www.orgbrain.no). It will be possible to attend the meeting in person or
digitally through Orgbrain.
Further information about participation and registration appears from the
notice.
Full agenda and documents are available on
https://lifecare.no/investor/governance/
About us
Lifecare ASA is a medical sensor company developing technology for sensing and
monitoring of various body analytes. Lifecare's main focus is to bring the
next generation of Continuous Glucose Monitoring ("CGM") systems to market.
Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor
technology is referred to as "Sencell" and is suitable for identifying and
monitoring the occurrence of a wide range of analytes and molecules in the
human body and in pets.
Contacts
For further information, please contact:
Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40
Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42
This information is subject to disclosure under the Norwegian Securities
Trading Act, ยง5-12. The information was submitted for publication at
2025-04-03 13:25 CEST.